Fall 2017 | CURE

Merkel Cell Carcinoma Joins the Cancers Treated With Checkpoint Inhibitor Immunotherapies

November 07, 2017

From the Chairman

IN THIS ISSUE OF CURE® magazine, we celebrate a first. In March, the immunotherapy Bavencio (avelumab) became the first treatment approved by the FDA specifically to treat the rare skin disease Merkel cell carcinoma, a neuroendocrine cancer of the skin.

How to Help Someone With Cancer

October 24, 2017


Author Shannon Benish knows what really makes a difference during a cancer journey. She saw her daughter, Erin, through hers, which began with a diagnosis at age 11 and led to remission and life as a healthy teenager.